A randomised, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) Study
| Autor: | Adlam, D, Uren, N, Oldroyd, K, Munir, S, Sharp, A, Zaman, A, Contractor, H, Kiss, R, Edes, I, Jr, ZM, Garcia, MJ, Musialek, P, Tomcsanyi, J, Ptaszynski, P, Nagy, G, Szachniewicz, J, Siegel, L, Shirodaria, C, Selvanayagam, JB, Tulloch, S, Investigators, Campfire, Channon, KM |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| DOI: | 10.1161/cir.0000000000000742 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|